Amundi’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Buy
47,583
+7,907
+20% +$98.8K ﹤0.01% 1537
2025
Q4
$513K Buy
39,676
+3,940
+11% +$50.6K ﹤0.01% 1466
2025
Q3
$518K Sell
35,736
-3,355
-9% -$44.8K ﹤0.01% 1318
2025
Q2
$699K Buy
39,091
+39,041
+78,082% +$680K ﹤0.01% 1287
2025
Q1
$849 Sell
50
-9
-15% -$204 ﹤0.01% 2058
2024
Q4
$1.71K Buy
+59
New +$1.25K ﹤0.01% 2002
2024
Q1
Sell
-60,000
Closed -$884K 2054
2023
Q4
$884K Buy
+60,000
New +$803K ﹤0.01% 1349
2023
Q3
Sell
-81,944
Closed -$3.47M 2050
2023
Q2
$3.47M Sell
81,944
-140,754
-63% -$8.74M ﹤0.01% 1053
2023
Q1
$13.8M Buy
222,698
+18,929
+9% +$1.51M 0.01% 771
2022
Q4
$19.7M Buy
203,769
+19,184
+10% +$1.44M 0.01% 698
2022
Q3
$15.7M Buy
184,585
+23,618
+15% +$1.84M 0.01% 742
2022
Q2
$11.7M Buy
160,967
+79,567
+98% +$5.99M 0.01% 738
2022
Q1
$7M Buy
81,400
+9,528
+13% +$702K ﹤0.01% 896
2021
Q4
$5.01M Buy
71,872
+2,842
+4% +$285K ﹤0.01% 996
2021
Q3
$8.02M Buy
69,030
+11,940
+21% +$1.81M 0.01% 898
2021
Q2
$12.7M Buy
+57,090
New +$11.1M 0.01% 780

Other funds holding NVCR